Cargando…
Current Status of Radical Prostatectomy for High-Risk Prostate Cancer
Despite the wide application of prostate-specific antigen-based screening leading to a profound stage migration in prostate cancer (PC), a significant percentage of men are still being diagnosed with clinically high-risk disease that requires aggressive treatment. Optimal management in these patient...
Autores principales: | Kang, Ho Won, Lee, Joo Yong, Kwon, Jong Kyou, Jeh, Seong Uk, Jung, Hae Do, Choi, Young Deuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198760/ https://www.ncbi.nlm.nih.gov/pubmed/25324944 http://dx.doi.org/10.4111/kju.2014.55.10.629 |
Ejemplares similares
-
Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
por: Kang, Ho Won, et al.
Publicado: (2016) -
The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2017) -
Pathologic Outcomes in Men with Low-risk Prostate Cancer Who Are Potential Candidates for Contemporary, Active Surveillance Protocols
por: Kang, Ho Won, et al.
Publicado: (2015) -
Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy
por: Kang, Yong Jin, et al.
Publicado: (2017) -
Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin
por: Kang, Yong Jin, et al.
Publicado: (2017)